ZIARCO PHARMA LTD has a total of 34 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are PHARMACIA ITALIA SPA, AXELAR AB and ARDENT PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United Kingdom | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Japan | 2 | |
#8 | Argentina | 1 | |
#9 | Australia | 1 | |
#10 | Brazil | 1 | |
#11 | Hong Kong | 1 | |
#12 | Hungary | 1 | |
#13 | Israel | 1 | |
#14 | Republic of Korea | 1 | |
#15 | Mexico | 1 | |
#16 | Norway | 1 | |
#17 | Serbia | 1 | |
#18 | Russian Federation | 1 | |
#19 | Slovenia | 1 | |
#20 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Yeadon Michael | 14 |
#2 | Liu Wai Leung | 11 |
#3 | Purkins Lynn | 10 |
#4 | Whitlock Gavin A | 5 |
#5 | Glossop Paul Alan | 5 |
#6 | Bell Andrew Simon | 5 |
#7 | Selby Matthew Duncan | 5 |
#8 | Mowbray Charles Eric | 5 |
#9 | Lane Charlotte Alice Louise | 5 |
#10 | Swain Nigel Alan | 5 |
Publication | Filing date | Title |
---|---|---|
TW201729810A | Pyrimidine compositions, ultra-pure compositions and salts thereof, methods of making the same, and methods of using the same for treating histamine H4 receptor (H4) mediated diseases and conditions | |
GB201501588D0 | Novel polymorph for use in treatment of inflammatory, skin and pruritic disorders | |
GB201418096D0 | Novel polymorph for use in treatment of inflammatory skin and pruritic disorders | |
GB201401904D0 | Pharmaceutical composition for topical administration | |
WO2014045029A1 | 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors |